Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Evil Rabbit's Profile
Displaying 1-50 of 6045 result(s).
CYDY CytoDyn Inc
09/10/2025 2:00:43 PM
Agree. I assume we close red today (6)
CYDY CytoDyn Inc
09/10/2025 9:30:41 AM
Somebody needs to be fired.
CYDY CytoDyn Inc
09/09/2025 4:35:02 PM
First person to make a post at any (8)
CYDY CytoDyn Inc
09/09/2025 1:49:18 PM
That’s your prerogative. But when (8)
CYDY CytoDyn Inc
09/09/2025 11:47:37 AM
I’m not sure anyone needs such an (2)
CYDY CytoDyn Inc
09/09/2025 11:14:12 AM
Just gotta ignore the noise and be (9)
CYDY CytoDyn Inc
09/04/2025 9:36:22 PM
He tried to steal Leronlimab for pe (13)
CYDY CytoDyn Inc
09/04/2025 2:49:15 PM
Least we forget, B.P. had a minion (11)
CYDY CytoDyn Inc
09/04/2025 1:53:31 PM
He’s why I, and likely many other (17)
CYDY CytoDyn Inc
08/29/2025 2:22:11 PM
I have never understood why Sascha (22)
CYDY CytoDyn Inc
08/27/2025 12:45:00 PM
At $10 I’m freakin’ selling! Aw (8)
CYDY CytoDyn Inc
08/25/2025 2:54:26 PM
I believe the ship is righted. But (6)
CYDY CytoDyn Inc
08/25/2025 2:45:17 PM
What was the full quote? I thought (3)
CYDY CytoDyn Inc
08/19/2025 12:43:30 PM
12 thumbs down. That’s impressive (10)
CYDY CytoDyn Inc
08/19/2025 11:28:36 AM
Add the 30+ I’ve deleted just thi (16)
CYDY CytoDyn Inc
08/19/2025 10:44:02 AM
Worst board member of all time and (15)
CYDY CytoDyn Inc
08/19/2025 10:19:52 AM
MODS’ fingers must be blistered (13)
CYDY CytoDyn Inc
08/18/2025 12:25:28 PM
It’s our ex-mod turned pest. He m (11)
CYDY CytoDyn Inc
08/11/2025 2:07:43 PM
Emmitt still has me on IGNORE so I (16)
CYDY CytoDyn Inc
08/08/2025 5:27:43 PM
Would dearly like to know why Max i (20)
CYDY CytoDyn Inc
08/08/2025 12:08:51 PM
Dr. Jay has been permanent CEO sin (4)
CYDY CytoDyn Inc
08/07/2025 5:58:23 PM
They’ve long been overly terrifie (9)
CYDY CytoDyn Inc
08/07/2025 2:36:52 PM
Okay, let’s bench the FOR and AGA (11)
CYDY CytoDyn Inc
08/07/2025 12:10:55 PM
The premise of your argument implie (8)
CYDY CytoDyn Inc
08/06/2025 4:35:55 PM
Plus a generous seasoning of negati (7)
CYDY CytoDyn Inc
08/06/2025 12:50:50 PM
Nobody here knows anything. There†(7)
CYDY CytoDyn Inc
08/04/2025 12:55:20 PM
Well, if we've had an arrangement w (5)
CYDY CytoDyn Inc
08/01/2025 8:49:12 PM
Thanks Wax. I’ve been out all day (8)
CYDY CytoDyn Inc
07/31/2025 1:18:01 PM
Hey Riz (NOMOD), You’ve been told (26)
CYDY CytoDyn Inc
07/28/2025 7:16:25 PM
Clinictrials.gov is always late to (2)
CYDY CytoDyn Inc
07/27/2025 11:09:09 AM
Based on the correction, I deleted (3)
CYDY CytoDyn Inc
07/26/2025 2:47:34 PM
I love a good pun. Thanks for the s (10)
CYDY CytoDyn Inc
07/26/2025 1:50:23 PM
Done. It really is unfortunate that (3)
CYDY CytoDyn Inc
07/26/2025 1:36:01 PM
Riz, what is your end game here? Wh (19)
CYDY CytoDyn Inc
07/23/2025 10:03:41 AM
That premarket action was some BS. (6)
CYDY CytoDyn Inc
07/18/2025 2:40:42 PM
I’ve posted metadata, federal sub (11)
CYDY CytoDyn Inc
07/18/2025 2:25:07 PM
Again, you’re not actually saying (15)
CYDY CytoDyn Inc
07/18/2025 1:54:22 PM
You’re inadvertently illustrating (12)
CYDY CytoDyn Inc
07/18/2025 12:05:31 PM
Also, any posts filled with email a (8)
CYDY CytoDyn Inc
07/18/2025 11:56:20 AM
If you’re conducting some kind of (20)
CYDY CytoDyn Inc
07/15/2025 3:03:31 PM
I'd take a PR around what Dr. J. ha (22)
CYDY CytoDyn Inc
07/07/2025 2:44:31 PM
Because he said he had you on ignor (9)
CYDY CytoDyn Inc
07/07/2025 2:41:27 PM
Language like that will get you bla (4)
CYDY CytoDyn Inc
07/07/2025 10:30:37 AM
The five-year anniversary of our RT (14)
CYDY CytoDyn Inc
07/03/2025 3:19:08 PM
He presents Leronlimab / CRC tomorr (2)
CYDY CytoDyn Inc
07/02/2025 6:46:30 PM
Immune checkpoint inhibitor. (1)
CYDY CytoDyn Inc
07/02/2025 2:37:26 PM
Excellent work, Riz. See if you can (4)
CYDY CytoDyn Inc
07/02/2025 11:33:20 AM
Paging Ken Chowder… I don’t use (1)
CYDY CytoDyn Inc
07/02/2025 12:11:21 AM
After years of doing this, I feel l (15)
CYDY CytoDyn Inc
07/01/2025 7:15:25 PM
Plenty of other boards will allow y (12)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • SERES Power Unveils Innovative Range-Extender Technology
  • Chipotle's Exciting Expansion Into Asia Via SPC Partnership
  • Reflecting on Resilience: Insights from Art Ally on 9/11
  • Steven J. Jerina Appointed Vice President at Central Florida Foundation
  • KBR, Inc. Shareholder Rights Investigation: What Investors Need to Know
  • Lyno AI: Transforming Investment Through AI-Driven Trading
  • Satlink and Rivada Join Forces for Cutting-Edge Connectivity Solutions
  • Snap Inc. Investors Must Act Before October Deadline for Class Action
  • Investors Affected by Fly-E Group, Inc. Lawsuit Alerted
  • Bitcoin's Ascent: An Insight into Market Trends and Tokens
  • Understanding the Trends in Automatic Data Processing Shares
  • Analysis of National Fuel Gas's Short Interest Trends
  • Understanding Annaly Capital's Growing Short Interest Dynamics
  • Transforming Leadership: Mike Walsh Joins DKBinnovative as CEO
  • Understanding the Impact of Geopolitical Tensions on ETFs
  • Increasing Blood Donations Key to Helping Sickle Cell Patients
  • Securing $340M Refinancing for 50 & 70 Columbus Project
  • Silverts Strengthens Adaptive Fashion with Strategic Acquisition
  • Opportunity Knocks: Victoria Tower Office Sale Unveiled
  • Lord Cameron Highlights Rare Disease Innovation at Morgan Stanley
  • Seguritech Celebrates 30 Years of Innovation in Security Tech
  • DePauw University Demonstrates Significant Local Economic Influence
  • FG Communities Strengthens Presence with Recent Acquisition
  • Investigation of Quanex Building Products: Key Insights and Updates
  • Investigation Launched for AVITA Medical Investors Amid Concerns
  • Pomerantz Firm Looks Into Geely Automobile Investor Concerns
  • Spectrum Pharmaceuticals Faces Legal Challenges - SPPI Update
  • Celebrating a Century of Community at John C. Campbell Folk School
  • AstraZeneca's Koselugo Approved for Younger Pediatric Patients
  • BioXcel Therapeutics Enhances Agitation Management with BXCL501
  • Breakthrough in Cancer Treatment: PMV Pharmaceuticals Updates
  • Oracle's Record Backlog and AI Growth Propel Stock Surge
  • Avidity Biosciences Achieves Promising Milestones in DMD Trials
  • Thriving Future for Trans-1,2-Dichloroethylene Market Growth
  • CIRO Schedules Hearing for Abid Hossain: Key Details Explained
  • Gartner Inc. Insights: Analyzing Current Stock Performance
  • Understanding Current Trends in Options Trading for Exxon Mobil
  • Landsbankinn hf. Concludes Successful Covered Bond Auction
  • Understanding the Current Trends in META's Options Market
  • Insights Into Circle Internet Group's Recent Trading Trends
  • Muinzer Welcomes New Director of Asset Management for Expansion
  • Biocon Expands Horizons with New U.S. Manufacturing Facility
  • VIVA Foundation to Present Breakthrough Vascular Research in 2025
  • Acadia Healthcare Faces Challenges with Medicaid Payment Cuts
  • Experience The Witcher Through Exclusive Eyewear Designs
  • NYBRA Plastic Surgery Partners with ARSA for Enhanced Care
  • Eraaya Lifespaces Appoints Gagan Sethi as New CEO for Growth
  • Satlink and Rivada: Pioneering Secure Satellite Solutions
  • Austin Company Unveils Advanced Spacecraft Manufacturing Hub
  • DePauw University's Significant Economic Contributions Explored
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site